International audienceBiosimilars marketing authorization requires a strict demonstration of similarity with the reference antibody, through preclinical and clinical studies. This article reviews the panel of in vitro physicochemical and functional analyses, which are performed prior to clinical studies. For each critical attribute of the antibody, we detail the commonly used analytical techniques, their working principle and the type of information they may give
<p>The antibodies are listed together with their specificities, suppliers, product codes, and the sp...
This thesis describes the development of novel mass spectrometric methods for the analysis of therap...
Monoclonal antibodies (MAs) are complex biotherapeutics as their molecular mechanism of action depen...
International audienceBiosimilars marketing authorization requires a strict demonstration of similar...
Therapeutic antibody assessment in biofluids requires fit-for-purpose bioanalytical methods. The ref...
For assessment of biosimilarity, the US Food and Drug Administration (FDA) recommends a stepwise app...
Abstract Monoclonal antibody (mAb)-based therapeutics are playing an increasingly important role in ...
Monoclonal antibodies (mAbs) are a fast-growing class of biopharmaceuticals. They are widely used in...
Antibody-based therapeutic classes are evolving from monoclonal antibodies to antibody derivatives w...
Monoclonal antibodies (mAbs) are the most dominant selling class of biotherapeutics in the global ma...
Contains fulltext : 171662.pdf (Publisher’s version ) (Open Access)Antibodies are ...
Biosimilar products are required by regulatory authorities to have appropriate and comparable qualit...
AbstractMonoclonal antibodies are large molecules with complex structure and functions. They have a ...
<div><p>An <i>In Vitro</i> Comparative Immunogenicity Assessment (IVCIA) assay was evaluated as a to...
According to PubMed, the term ‘biosimilar’ has existed for 10 years in scientific literature, with t...
<p>The antibodies are listed together with their specificities, suppliers, product codes, and the sp...
This thesis describes the development of novel mass spectrometric methods for the analysis of therap...
Monoclonal antibodies (MAs) are complex biotherapeutics as their molecular mechanism of action depen...
International audienceBiosimilars marketing authorization requires a strict demonstration of similar...
Therapeutic antibody assessment in biofluids requires fit-for-purpose bioanalytical methods. The ref...
For assessment of biosimilarity, the US Food and Drug Administration (FDA) recommends a stepwise app...
Abstract Monoclonal antibody (mAb)-based therapeutics are playing an increasingly important role in ...
Monoclonal antibodies (mAbs) are a fast-growing class of biopharmaceuticals. They are widely used in...
Antibody-based therapeutic classes are evolving from monoclonal antibodies to antibody derivatives w...
Monoclonal antibodies (mAbs) are the most dominant selling class of biotherapeutics in the global ma...
Contains fulltext : 171662.pdf (Publisher’s version ) (Open Access)Antibodies are ...
Biosimilar products are required by regulatory authorities to have appropriate and comparable qualit...
AbstractMonoclonal antibodies are large molecules with complex structure and functions. They have a ...
<div><p>An <i>In Vitro</i> Comparative Immunogenicity Assessment (IVCIA) assay was evaluated as a to...
According to PubMed, the term ‘biosimilar’ has existed for 10 years in scientific literature, with t...
<p>The antibodies are listed together with their specificities, suppliers, product codes, and the sp...
This thesis describes the development of novel mass spectrometric methods for the analysis of therap...
Monoclonal antibodies (MAs) are complex biotherapeutics as their molecular mechanism of action depen...